SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-048706
Filing Date
2018-09-10
Accepted
2018-09-10 06:03:52
Documents
3
Period of Report
2018-09-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv502606_8k.htm 8-K 31933
2 EXHIBIT 99.1 tv502606_ex99-1.htm EX-99.1 35165
3 GRAPHIC image_001.jpg GRAPHIC 5964
  Complete submission text file 0001144204-18-048706.txt   76830
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 181061361
SIC: 8731 Services-Commercial Physical & Biological Research